2015
DOI: 10.1016/j.jacc.2015.04.066
|View full text |Cite|
|
Sign up to set email alerts
|

Adenosine and Clinical Forms of Neurally-Mediated Syncope

Abstract: nus bradycardia and/or atrioventricular block.For patients with typical VVS, a combination of neural outflow and purinergic activation is likely. Letters J A C C V O L . 6 6 , N O . 2 , 2 0 1 5 J U L Y 1 4 , 2 0 1 5 : 2 0 2 -7 R E F E R E N C E S 1. Deharo JC, Mechulan A, Giorgi R, et al. Adenosine plasma level and A2A adenosine receptor expression: correlation with laboratory tests in patients with neurally mediated syncope. Heart 2012;98:855-9. 2. Deharo JC, Guieu R, Mechulan A, et al. Syncope without prodro… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

3
46
0
4

Year Published

2016
2016
2021
2021

Publication Types

Select...
7

Relationship

3
4

Authors

Journals

citations
Cited by 40 publications
(53 citation statements)
references
References 5 publications
3
46
0
4
Order By: Relevance
“…While the K D for A 2A R of the agonist used here to mimic adenosine was similar in patients and controls, the EC 50 value (related to the biological effect triggered by the Spare A 2A R was first observed in guinea pig cardiac tissue using an irreversible A 2A R antagonist to block response to various agonists (13). Here, we used an agonist-like monoclonal antibody and provided further evidence for the presence of spare A 2A R on the surface of human mononuclear cells in relation to cardiac dysfunction, spare A 2A R having already been observed in a context of neurocardiogenic syncope, but not in healthy subjects (14,15,18).…”
Section: Discussionmentioning
confidence: 72%
See 1 more Smart Citation
“…While the K D for A 2A R of the agonist used here to mimic adenosine was similar in patients and controls, the EC 50 value (related to the biological effect triggered by the Spare A 2A R was first observed in guinea pig cardiac tissue using an irreversible A 2A R antagonist to block response to various agonists (13). Here, we used an agonist-like monoclonal antibody and provided further evidence for the presence of spare A 2A R on the surface of human mononuclear cells in relation to cardiac dysfunction, spare A 2A R having already been observed in a context of neurocardiogenic syncope, but not in healthy subjects (14,15,18).…”
Section: Discussionmentioning
confidence: 72%
“…The presence of spare A 2A R in CAD patients and its role in CAD pathophysiology in which the regulation of myocardial blood flow is altered have never been addressed, and we hypothesized that spare A 2A R is present in CAD patients to try to correct myocardial ischemia. We therefore undertook in this study to test the pharmacological characteristics of A 2A R present on peripheral blood mononuclear cells (PBMC) because i) this cell population is readily accessible compared with coronary tissues and ii) properties of A 2A R on PBMC appear to be similar to those of A 2A R in heart tissue as changes in PBMC-surface expression of A 2A R occur in cardiovascular diseases are associated with adenosine metabolism abnormalities (16)(17)(18), which suggests that regulation of A 2A R expression may be a systemic mechanism.…”
Section: Est Proceduresmentioning
confidence: 99%
“…This high APC is responsible for the drop in blood pressure and loss of consciousness. Conversely, low adenosine is associated with sudden syncope [2,3]. This last kind of syncope has a more pejorative prognosis because lacking prodromes and because the cause of loss of consciousness is often atrio-ventricular block [3].…”
Section: Discussionmentioning
confidence: 99%
“…Adenosine is an ATP derivative that is implicated in a lot of cardiovascular and neurological diseases including neurocardiogenic syncope [1][2][3], coronary artery diseases [4,5], neuropathic pain [6], septic shock [7] and severe systemic inflammatory response [8]. Thus, measurig adenosine in blood may be helpful for some pathologies.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation